Aug 2026
LTBP4 deficiency induces MRC1+/CD44+ macrophages to drive cancer progression in preclinical colorectal cancer models.
This study positions LTBP4 as a key modulator of tumor progression and reveals a therapeutic strategy for LTBP4-deficient CRC.
Songtao Ji, Shuya Du, Ge Miao et al.
· Science Translational Medici... · 0 citations